ARTL Total Aset Bisnis Artelo

Artelo Biosciences (ARTL) focuses on studying cannabinoid therapies, optimizing supply chains and its contract base to mitigate risks. The company maintains its intellectual capital by recruiting top biochemists and compliance experts. This chart of total asset quotes shows a value of 5.41. The business model relies on outsourcing formula synthesis and clinical trials to external partners, allowing Artelo Biosciences (ARTL) to operate as a pure scientific hub.

Aset Agregat Perusahaan Artelo (ARTL): kanggo periode 04.07.2022 - 30.10.2026

Rincian analitis lan laporan data perusahaan artelobio.com (ARTL)

- rega saham lan konsensus proyeksi valuasi:

Bagan rega Artelo Biosciences, Inc.|ARTL - Bagan rega target

- data kapitalisasi pasar:

Kapitalisasi pasar Artelo Biosciences, Inc.|ARTL - Nilai Perusahaan

- informasi kapitalisasi buku:

Nilai Buku saben Saham Artelo Biosciences|ARTL - Nilai Buku Perusahaan|Nilai Pasar marang Nilai Buku artelobio.com|ARTL - Total Aset Perusahaan

- indikator beban utang lan likuiditas:

Rasio Total Utang marang Ekuitas Artelo Biosciences|ARTL - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal Artelo Biosciences, Inc.|ARTL - Gunggung utang perusahaan|Rasio utang marang aset resik Artelo Biosciences, Inc.|ARTL - Utang jangka dawa perusahaan|Kewajiban jangka cendhak Artelo Biosciences|Rasio cepet artelobio.com

- rincian bathi lan kelipatan pasar:

ARTL - Bathi resik perusahaan

Ringkesan analisis perusahaan:Artelo (ARTL)

Developing innovative drugs for cancer therapy and chronic pain requires significant resources; therefore, total assets, representing the sum of capital and liabilities, determine the financial scale of Artelo Biosciences (ARTL). A reverse calculation via ROA allows investors to perform a real-time assessment of asset utilization efficiency, where monitoring the company's total assets reveals the balance between R&D investments and the risk of freezing illiquid capital.

Pesaing langsung